(-0.04%) 5 210.75 points
(-0.18%) 39 126 points
(0.01%) 18 189 points
(0.76%) $79.59
(0.78%) $2.20
(0.55%) $2 335.00
(1.95%) $28.14
(0.11%) $985.70
(-0.05%) $0.930
(-0.06%) $10.88
(-0.02%) $0.800
(1.12%) $92.76
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 11.36%
-5.18% $ 12.08
@ $23.86
Wydano: 14 vas. 2024 @ 22:16
Zwrot: -49.37%
Poprzedni sygnał: vas. 14 - 17:40
Poprzedni sygnał:
Zwrot: 0.08 %
Live Chart Being Loaded With Signals
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 1.04M |
Średni wolumen | 1.14M |
Kapitalizacja rynkowa | 565.40M |
EPS | $0 ( 2024-03-21 ) |
Następna data zysków | ( $-0.480 ) 2024-06-03 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.32 |
ATR14 | $0.0230 (0.19%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Gerard Michael | Buy | 100 000 | Stock Option (Right to Buy) |
2024-03-01 | Chang David J. | Buy | 130 000 | Stock Option (Right to Buy) |
2024-03-01 | Nichtberger Steven | Buy | 353 000 | Stock Option (Right to Buy) |
2024-03-01 | Marda Anup | Buy | 130 000 | Stock Option (Right to Buy) |
2024-03-01 | Das Arun | Buy | 100 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
82.18 |
Last 97 transactions |
Buy: 4 947 826 | Sell: 1 979 584 |
Wolumen Korelacja
Cabaletta Bio Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
NETE | 0.925 |
MMAC | 0.918 |
AMRB | 0.918 |
RPTX | 0.909 |
PRFT | 0.904 |
DMRC | 0.901 |
STIM | 0.9 |
LUNA | 0.896 |
GDYN | 0.89 |
PDSB | 0.889 |
10 Najbardziej negatywne korelacje | |
---|---|
RMRM | -0.919 |
NEXI | -0.917 |
MARA | -0.914 |
SVAC | -0.908 |
ITRM | -0.9 |
PAIC | -0.898 |
SRZN | -0.892 |
NOTV | -0.887 |
LPTX | -0.887 |
PRVA | -0.886 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cabaletta Bio Inc Korelacja - Waluta/Towar
Cabaletta Bio Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.43M (0.00 %) |
EPS: | $-1.650 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.43M (0.00 %) |
EPS: | $-1.650 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-3.68M (0.00 %) |
EPS: | $-1.770 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-2.15 |
Financial Reports:
No articles found.
Cabaletta Bio Inc
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej